One laser, two clinical applications… Meridian’s Merilas 810 short-pulse laser provides treatments for retina and glaucoma, including advanced and end-stage glaucoma. Offering transscleral cyclophotocoagulation (TSCPC), the Merilas 810 has been shown to reduce intraocular pressure in patients where previous medications and treatments were not effective.
The Merilas 810’s innovative thermal-electrical cooling system ensures quiet operation. With no need for ventilation slots, dust is prevented from penetrating the interior of the laser, improving longevity and reliability. Meridian has been developing, manufacturing, and maintaining ophthalmic lasers for more than 35 years and Device Technologies is the exclusive distributor of the Meridian laser range in Australia and New Zealand.
Contact: Device Technologies (AUS) 1300 338 423
